News Releases | CSL

Month Year

Month Year

Aug 8, 2017

Vifor Pharma Reports Strong H1 2017 Results and Raises Guidance

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
Jul 21, 2017

European Commission Approves Marketing Authorisation for Veltassa®

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
Jul 18, 2017

New Expert Review in the American Journal of Hematology Seeks to Change the Way We Test, Treat and Talk About Iron Deficiency in Chronic Inflammatory Conditions

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
Jul 12, 2017

Vifor Pharma Announces Three Outcomes Trials in Heart Failure and Iron Deficiency

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
Jun 9, 2017

Kissei to Market Avacopan in Japan for Vifor Fresenius Medical Care Renal Pharma

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
May 19, 2017

Chmp Recommends Veltassa® for the Treatment of Hyperkalaemia in the Eu

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
May 16, 2017

Vifor Pharma and Akebia Announce Exclusive License Agreement to Provide Vadadustat to Fresenius Medical Care in the U.s. Upon Fda Approval

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
May 11, 2017

89th Annual General Meeting of Galenica Ltd.

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
Apr 12, 2017

Galenica Santé Ipo – Full Exercise of Over-allotment Option

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases
Apr 7, 2017

Successful Galenica Santé Ipo, Galenica Group Becomes Vifor Pharma Group

PDF VERSION OF PRESS RELEASE Back to overview of Press Releases

Show per page

Filter by Company: